IDEX Corporation provided earnings guidance for the second quarter and full year 2022. Full year 2022 organic sales growth is projected to be 6% to 8%, with an 8% to 9% organic sales increase in the second quarter of 2022 versus the prior year period. The company expected full year 2022 reported EPS attributable to IDEX of $6.87 to $7.00 and second quarter 2022 reported EPS attributable to IDEX of $1.69 to $1.74.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218 USD | +0.40% | -2.77% | +0.41% |
16/05 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
08/05 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.41% | 16.5B | |
-4.33% | 14.04B | |
-6.21% | 5.13B | |
+2.47% | 4.56B | |
+7.43% | 3.14B | |
+31.53% | 1.94B | |
+91.01% | 1.63B | |
+0.75% | 1.22B | |
+18.66% | 1.02B | |
-6.56% | 870M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- IDEX Corporation Provides Earnings Guidance for the Second Quarter and Full Year 2022